Quick Takeaways
- BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A for Prelude Therapeutics Inc Common Stock, $0.0001 par value per share (PRLD).
- Disclosed ownership: 24%.
- Date of event: 12 Jun 2025.
BAKER BROS. ADVISORS LP - 12 Jun 2025 SCHEDULE 13D/A Report for Prelude Therapeutics Inc Common Stock, $0.0001 par value per share (PRLD)
- Filing Manager
- BAKER BROS. ADVISORS LP
- Reporting Manager
- Baker Bros. Advisors LP
- Symbol
- PRLD
- Shares outstanding
- 43,701,991 shares
- Disclosed Ownership
- 10,269,968 shares
- Ownership
- 24%
- Form type
- SCHEDULE 13D/A
- Filing time
- 13 Jun 2025, 17:21:09 UTC
- Date of event
- 12 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAKER BROS. ADVISORS LP disclosed 24% ownership in Prelude Therapeutics Inc Common Stock, $0.0001 par value per share (PRLD) on 12 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Jun 2025, 17:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 24% | 10,269,968 | 10,269,968 | 0 | /s/ Scott L. Lessing | By: Baker Bros. Advisors (GP) LLC, its general partner, Scott L. Lessing/ President | 0001263508 |
| Baker Bros. Advisors (GP) LLC | 24% | 10,269,968 | 10,269,968 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/ President | 0001580575 |
| Julian C. Baker | 24% | 10,269,968 | 10,269,968 | 0 | /s/ Julian C. Baker | Julian C. Baker | 0001087939 |
| Felix J. Baker | 24% | 10,269,968 | 10,269,968 | 0 | /s/ Felix J. Baker | Felix J. Baker | 0001087940 |